Skip to content
Fringe Wellness

Emerging wellness, examined.

GHK-Cu

Also discussed as: Copper tripeptide-1

A copper-binding peptide used in cosmetic research and consumer skin products. That is not the same as an approved drug indication for healing or longevity.

GHK-Cu

Regulatory status
Not FDA approved
Human evidence
Very limited
Preclinical evidence
Developing
Known risks
See evidence review
Major unknowns
Long-term safety
Standardized human dosing
Clinical effectiveness
Last evidence review
2026-09-24
Last regulatory review
2026-09-24

A copper-binding peptide used in cosmetic research and consumer skin products. That is not the same as an approved drug indication for healing or longevity.

Why it is trending: public search and clinic marketing have moved faster than a settled human evidence base. This page does not score that attention as benefit or safety.

Human evidence

Human evidence is very limited for a consumer conclusion, except where an approved labeling exists for a specific indication. This review does not invent trial results.

Preclinical evidence

Animal and laboratory papers exist for several of these compounds. Preclinical work does not establish human effectiveness.

Risks and unknowns

Known risks include an incomplete human safety picture and, outside regulated manufacturing, uncertain product identity. Major unknowns include long-term safety, standardized human dosing, and clinical effectiveness.

Reviewed 24 September 2026. Regulatory status can change. Check the FDA record before treating any sentence here as current law.

Related reading

Sources

  1. FDA drugs database and consumer updates
  2. ClinicalTrials.gov
  3. PubMed

This page is journalism and research literacy. It is not medical advice and not a product recommendation.